Increased T regulatory cells are associated with adverse clinical features and predict progression in multiple myeloma. by Karthick Raja Muthu Raja, Lucie Rihova, Lenka Zahradova, Maria Klincova, Miroslav Penka, Roman Hajek

Get full text

Plasmacytoid Dendritic Cells in Patients with MGUS and Multiple Myeloma by Andrea Knight, Lucie Rihova, Romana Kralova, Miroslav Penka, Zdenek Adam, Ludek Pour, Martin Piskacek, Roman Hajek

Get full text

Analysis of von Willebrand Disease in the “Heart of Europe” by Inge Vangenechten, Petr Smejkal, Jiri Zavrelova, Ondrej Zapletal, Alexander Wild, Jan Jacques Michiels, Zwi Berneman, Jan Blatny, Angelika Batorova, Tatiana Prigancova, Miroslav Penka, Alain Gadisseur

Get full text

Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma. by Lenka Besse, Lenka Sedlarikova, Fedor Kryukov, Jana Nekvindova, Lenka Radova, Ondrej Slaby, Petr Kuglik, Martina Almasi, Miroslav Penka, Marta Krejci, Zdenek Adam, Ludek Pour, Sabina Sevcikova, Roman Hajek

Get full text